Phase 3 Study Of Perioperative Pembrolizumab Or Pembrolizumab Plus Enfortumab Vedotin And Cystectomy Versus Cystectomy Alone In Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer: Keynote-905/Ev-303
Pembrolizumab;Enfortumab Vedotin
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 3 Study Of Perioperative Pembrolizumab Or Pembrolizumab Plus Enfortumab Vedotin And Cystectomy Versus Cystectomy Alone In Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer: Keynote-905/Ev-303 ### Output: Pembrolizumab;Enfortumab Vedotin